SGMT · Sagimet Biosciences Inc.
Market Cap
$661.99M
Shares
62.16M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-08-14 | GEORGE KEMBLE | Director | 350,987 | 2026-08-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-11 | GEORGE KEMBLE | Director | 20,206 | 2026-08-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-20 | GEORGE KEMBLE | Director, Officer | 18,844 | 2026-07-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-20 | GEORGE KEMBLE | Director, Officer | 37,688 | 2025-11-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-07-23 | GEORGE KEMBLE | Director, Officer | 23,625 | 2024-07-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–5 of 5 filings
Key facts
CIK
1400118
CUSIP
786700104
13F (30d)
111 filings
110 filers
Visit website
Investor relations